Skip to main content
SBIO logo

ALPS Medical Breakthroughs ETF (SBIO)

SBIONYSEARCASS&CEquity

$50.95Today:−$0.36 (−0.71%)1Y +11.64%

As of Nov 20, 2026 close

Assets (AUM)
$211.51M
Expense ratio
0.50%
Dividend yield
-
Holdings
107
52-week range
$45.65$70.85
Volume (live)
-
Avg. volume (3M)
27.14K

SBIO ETF Holdings: ALPS Medical Breakthroughs ETF

The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.

Total Holdings
107
Updated Oct 4, 2026
Top 10 Holdings
32.5%
Share of fund assets
Assets (AUM)
$211.51M
Total fund assets
Expense Ratio
0.50%
Annual management fee

Portfolio Allocations

Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.

Loading chart...

Top 49 of 107 SBIO Holdings by Portfolio Weight

Holdings data last updated Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 49 positions.

Scroll to see more
SBIO ETF holdings table showing rank, ticker symbol, company name, asset type, and portfolio weight percentage, sorted by portfolio weight, last updated Oct 4, 2026.
#SymbolNameTypeWeight
1
CGON logo
CGON
CG Oncology, Inc.Stock3.88%
2
ORKA logo
ORKA
Oruka Therapeutics, Inc.Stock3.64%
3
TVTX logo
TVTX
Travere Therapeutics, Inc.Stock3.49%
4
DNTH logo
DNTH
Dianthus Therapeutics Inc.Stock3.43%
5
DFTX logo
DFTX
Definium Therapeutics, Inc.Stock3.27%
6
XENE logo
XENE
Xenon Pharmaceuticals IncStock3.25%
7
MANE logo
MANE
Veradermics, IncorporatedStock3.17%
8
EWTX logo
EWTX
Edgewise Therapeutics, Inc.Stock2.92%
9
ACAD logo
ACAD
ACADIA Pharmaceuticals IncStock2.74%
10
RLAY logo
RLAY
Relay Therapeutics, Inc.Stock2.70%
11
IDYA logo
IDYA
IDEAYA Biosciences, Inc.Stock2.34%
12
AMLX logo
AMLX
Amylyx Pharmaceuticals, Inc.Stock2.27%
13
DNLI logo
DNLI
Denali Therapeutics Inc.Stock2.08%
14
TARS logo
TARS
Tarsus Pharmaceuticals, Inc.Stock2.08%
15
DYN logo
DYN
Dyne Therapeutics, Inc.Stock1.85%
16
MBX logo
MBX
MBX Biosciences, Inc.Stock1.83%
17
CLDX logo
CLDX
Celldex Therapeutics IncStock1.81%
18
NAMS logo
NAMS
NewAmsterdam Pharma Company N.V.Stock1.80%
19
ZLAB logo
ZLAB
Zai Lab LimitedStock1.78%
20
GPCR logo
GPCR
Structure Therapeutics Inc. American Depositary SharesStock1.66%
21
IMNM logo
IMNM
Immunome, IncStock1.62%
22
IRON logo
IRON
Disc Medicine, Inc.Stock1.61%
23
SLS logo
SLS
SELLAS Life Sciences Group, Inc.Stock1.54%
24
MLYS logo
MLYS
Mineralys Therapeutics Inc. Common StockStock1.53%
25
VERA logo
VERA
Vera Therapeutics IncStock1.45%
26
VRDN logo
VRDN
Viridian Therapeutics IncStock1.44%
27
NKTR logo
NKTR
Nektar TherapeuticsStock1.35%
28
SRPT logo
SRPT
Sarepta Therapeutics, IncStock1.31%
29
PVLA logo
PVLA
Palvella Therapeutics, IncStock1.30%
30
GENB logo
GENB
Generate Biomedicines, Inc. Common StockStock1.24%
31
BCRX logo
BCRX
BioCryst Pharmaceuticals IncStock1.24%
32
RAPP logo
RAPP
Rapport Therapeutics, Inc. Common StockStock1.22%
33
VCEL logo
VCEL
Vericel CorporationStock1.21%
34
NUVB logo
NUVB
Nuvation Bio IncStock1.21%
35
ZBIO logo
ZBIO
Zenas BioPharma, Inc. Common StockStock1.21%
36
AGIO logo
AGIO
Agios Pharmaceuticals, IncStock1.17%
37
CMPS logo
CMPS
COMPASS Pathways plcStock1.11%
38
GLPG
Galapagos NV ADRStock1.09%
39
XNCR logo
XNCR
Xencor, IncStock1.05%
40
STOK logo
STOK
Stoke Therapeutics, IncStock1.05%
41
KLRA logo
KLRA
Kailera Therapeutics, Inc. Common StockStock1.04%
42
IMCR logo
IMCR
Immunocore Holdings plcStock0.97%
43
BCAX logo
BCAX
BCAXStock0.89%
44
TSHA logo
TSHA
Taysha Gene Therapies, IncStock0.87%
45
MAZE logo
MAZE
Maze Therapeutics, Inc. Common StockStock0.80%
46
AVBP logo
AVBP
ArriVent BioPharma, Inc. Common StockStock0.78%
47
LBRX logo
LBRX
LB Pharmaceuticals Inc Common StockStock0.74%
48
SPTX logo
SPTX
Seaport Therapeutics, Inc. Common StockStock0.74%
49
VOR logo
VOR
Vor Biopharma IncStock0.72%

Source: Fund holdings disclosures. Last updated Oct 4, 2026. Data sources and methodology

Frequently Asked Questions About ALPS Medical Breakthroughs ETF Holdings

What are the top holdings in SBIO?

In holdings data last updated Oct 4, 2026, SBIO's largest holdings are CG Oncology, Inc. (CGON) at 3.88%, Oruka Therapeutics, Inc. (ORKA) at 3.64%, Travere Therapeutics, Inc. (TVTX) at 3.49%, Dianthus Therapeutics Inc. (DNTH) at 3.43% and Definium Therapeutics, Inc. (DFTX) at 3.27%. Together these 5 positions make up 17.7% of the fund. SBIO holds 107 securities in all; the holdings data lists the top 49 by weight.

How concentrated is SBIO's portfolio?

In holdings data last updated Oct 4, 2026, the 10 largest of SBIO's 107 positions make up 32.5% of assets. The largest single position is CG Oncology, Inc. (CGON) at 3.88%. The top 49 listed positions add up to 85.5%, so the remaining 58 holdings share 14.5%. Its largest sector, Healthcare, is 100.0% of the portfolio.

What is SBIO's sector allocation?

In holdings data last updated Oct 4, 2026, SBIO's largest sector weights are Healthcare (100.0%), together 100.0% of the portfolio. It has exposure to 1 sector in total.

What countries does SBIO invest in?

In holdings data last updated Oct 4, 2026, 91.5% of SBIO's portfolio is invested in the United States, followed by Netherlands (3.5%), Canada (2.0%) and Switzerland (1.6%). SBIO has exposure to 6 countries in total. By asset type the fund is 99.8% stocks and 0.2% cash.